Post-operative radiotherapy (PORT) or chemoradiotherapy (CPORT) following resection of stages II and IIIA non-small cell lung cancer (NSCLC) does not increase the expected risk of death from intercurrent disease (DID) in Eastern Cooperative Oncology Group (ECOG) trial E3590

Authors:
  • PSPatricia Stephenson
    Patricia Stephenson
  • SKSteven M. Keller
    Steven M. Keller
  • HWHenry Wagner
    Henry Wagner
  • AHArnold Herskovic
    Arnold Herskovic
  • RKRitsuko Komaki
    Ritsuko Komaki
  • RMRandolph S. Marks
    Randolph S. Marks
  • MPMichael C. Perry
    Michael C. Perry
  • RLRobert B. Livingston
    Robert B. Livingston
  • DJDavid H. Johnson
    David H. Johnson

Abstract
No abstract available

This publication has 32 references indexed in Scilit: